| AChE inhibition - acute mortality |
AdverseOutcome |
Cataia Ives (send email) |
Under Development: Contributions and Comments Welcome |
Under Development |
| sodium channel modulation |
AdverseOutcome |
Arthur Author (send email) |
Under Development: Contributions and Comments Welcome |
|
| chemical-induced arrthymias |
AdverseOutcome |
Allie Always (send email) |
Under Development: Contributions and Comments Welcome |
|
| GluCl activation to mortality |
AdverseOutcome |
Brendan Ferreri-Hanberry (send email) |
Under Development: Contributions and Comments Welcome |
|
| iGABAR activation leading to mortality |
AdverseOutcome |
Cataia Ives (send email) |
Under development: Not open for comment. Do not cite |
|
| GluCl activation leading to mortality |
AdverseOutcome |
Brendan Ferreri-Hanberry (send email) |
Under development: Not open for comment. Do not cite |
|
| OAT1 inhibition |
AdverseOutcome |
Brendan Ferreri-Hanberry (send email) |
Under Development: Contributions and Comments Welcome |
|
| Cox1 inhibition renal failure |
AdverseOutcome |
Agnes Aggy (send email) |
Under Development: Contributions and Comments Welcome |
|
| unknown MIE renal failure |
AdverseOutcome |
Cataia Ives (send email) |
Under Development: Contributions and Comments Welcome |
|
| AChE inhibition - acute mortality via predation |
AdverseOutcome |
Allie Always (send email) |
Under development: Not open for comment. Do not cite |
|
| SARS-CoV-2 leads to acute respiratory distress |
AdverseOutcome |
Evgeniia Kazymova (send email) |
Open for comment. Do not cite |
Under Development |
| DIO2i posterior swim bladder |
AdverseOutcome |
Brendan Ferreri-Hanberry (send email) |
Under Development: Contributions and Comments Welcome |
WPHA/WNT Endorsed |
| DIO2i anterior swim bladder |
AdverseOutcome |
Arthur Author (send email) |
Under Development: Contributions and Comments Welcome |
WPHA/WNT Endorsed |
| DIO1i posterior swim bladder |
AdverseOutcome |
Agnes Aggy (send email) |
Under Development: Contributions and Comments Welcome |
WPHA/WNT Endorsed |
| DIO1i anterior swim bladder |
AdverseOutcome |
Allie Always (send email) |
Under Development: Contributions and Comments Welcome |
WPHA/WNT Endorsed |
| TPOi anterior swim bladder |
AdverseOutcome |
Evgeniia Kazymova (send email) |
Under Development: Contributions and Comments Welcome |
WPHA/WNT Endorsed |
| TPOi retinal layer structure |
AdverseOutcome |
Allie Always (send email) |
Open for citation & comment |
EAGMST Under Review |
| TLR9 activation leading to Multi Organ Failure and ARDS |
AdverseOutcome |
Cataia Ives (send email) |
Under development: Not open for comment. Do not cite |
|
| TPOi eye size |
AdverseOutcome |
Evgeniia Kazymova (send email) |
Under development: Not open for comment. Do not cite |
Under Development |
| TPOi photoreceptor patterning |
AdverseOutcome |
Cataia Ives (send email) |
Under development: Not open for comment. Do not cite |
Under Development |
| Inhibition of Fyna leading to increased mortality |
AdverseOutcome |
Brendan Ferreri-Hanberry (send email) |
Open for citation & comment |
|
| Oxidation of Reduced Glutathione Leading to Mortality |
AdverseOutcome |
Agnes Aggy (send email) |
Open for citation & comment |
|
| GSK3beta inactivation leads to increased mortality |
AdverseOutcome |
Cataia Ives (send email) |
Open for citation & comment |
|
| Organo-Phosphate Chemicals leading to sensory axonal peripheral neuropathy and mortality |
AdverseOutcome |
Allie Always (send email) |
Under development: Not open for comment. Do not cite |
|